Market Research Logo

Switzerland Pharmaceuticals and Healthcare Report Q2 2016

Switzerland Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Switzerland's epidemiological profile will continue to be attractive to manufacturers of medicines for non-communicable diseases. Despite the relative rapid uptake of innovative pharmaceuticals, the burden of chronic conditions will account for a large proportion of the total disease burden over the next 15 years. Like many other developed states, Switzerland is introducing cost-containment measures to restrict the commercial opportunities presented to drugmakers.

Headline Expenditure Projections

Pharmaceuticals: CHF7.07bn (USD7.34bn) in 2015 to CHF7.07bn (USD6.88bn) in 2016; +0.08% in local currency terms and -6.3% in US dollar terms.

Healthcare: CHF71.83bn (USD74.60bn) in 2015 to CHF73.40bn (USD71.40bn) in 2016; +2.2% growth in local currency terms and -4.3% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (2013-2019)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Switzerland 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Switzerland 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Switzerland 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Switzerland 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Switzerland 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Switzerland 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Switzerland 2012-2020)
OTC Medicine Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Switzerland 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Switzerland 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Switzerland 2014-2020)
Industry Risk/Reward Index
Western Europe Risk/Reward Index
Switzerland Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Table: 2013 & 2014: Health Insurance Premiums
Table: Healthcare Resources (Switzerland 2010-2015)
Table: Healthcare Personnel (Switzerland 2010-2015)
Table: Healthcare Activity (Switzerland 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Retail Sector
Company Profile
Novartis
Roche
GlaxoSmithKline
Demographic Forecast
Table: Population Headline Indicators (Switzerland 1990-2025)
Table: Key Population Ratios (Switzerland 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Switzerland 1990-2025)
Table: Population By Age Group (Switzerland 1990-2025)
Table: Population By Age Group % (Switzerland 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report